Vergoeding 2015-2019 voor ATC-subgroep N03AX : Overige anti-epileptica

  • Raming voor de totale Zvw-populatie
  2015 2016 2017 2018 2019
N03AX03 Sultiam (Ospolot ®) 1 155 . . .
N03AX09 Lamotrigine (Lamictal ®) 2.572.100 2.558.600 2.435.600 2.692.300 2.750.300
N03AX10 Felbamaat (Taloxa ®) 134.530 128.000 132.360 118.920 118.160
N03AX11 Topiramaat (Topamax ®) 998.200 972.640 905.130 1.107.200 1.296.000
N03AX12 Gabapentine (Neurontin ®) 1.514.300 1.478.400 1.388.500 1.584.900 1.870.300
N03AX14 Levetiracetam (Keppra ®) 6.031.800 5.754.900 4.737.100 5.208.700 5.176.600
N03AX15 Zonisamide (Zonegran ®) 491.640 506.320 439.040 383.930 367.280
N03AX16 Pregabaline (Lyrica ®) 43.696.200 31.931.900 23.810.300 9.321.000 8.454.400
N03AX17 Stiripentol (Diacomit ®) 417.710 397.340 450.630 451.630 421.600
N03AX18 Lacosamide (Vimpat ®) 2.533.400 3.006.800 3.569.500 4.197.800 4.908.900
N03AX21 Retigabine 24.750 21.523 1.488 . .
N03AX22 Perampanel (Fycompa ®) 386.940 527.780 548.030 593.370 674.360
N03AX23 Brivaracetam (Briviact ®) . 48.261 436.970 948.830 1.654.400
Totaal 58.801.571 47.332.619 38.854.648 26.608.580 27.692.300